MedPath

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal Rhabdomyosarcoma

Phase 2
Conditions
Sarcoma
Registration Number
NCT00245141
Lead Sponsor
Japan Rhabdomyosarcoma Study Group
Brief Summary

RATIONALE: Drugs used in chemotherapy, such as vincristine, dactinomycin, and cyclophosphamide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Radiation therapy uses high energy x-rays to kill tumor cells. Giving more than one drug (combination chemotherapy) with radiation therapy may kill more tumor cells.

PURPOSE: This phase II trial is studying how well giving vincristine, dactinomycin, and cyclophosphamide together with or without radiation therapy works in treating patients with embryonal rhabdomyosarcoma.

Detailed Description

OBJECTIVES:

* Determine the progression-free survival rate in patients with low-risk embryonal rhadomyosarcoma treated with a shortened treatment schedule of vincristine, dactinomycin, and cyclophosphamide with or without radiotherapy.

OUTLINE: Patients receive vincristine IV, dactinomycin IV, and cyclophosphamide IV. Patients may also undergo radiotherapy. Treatment repeats every 3 weeks for up to 8 courses (total of 24 weeks) in the absence of disease progression or unacceptable toxicity.

PROJECTED ACCRUAL: A total of 32 patients will be accrued for this study.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
32
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Disease-free survival as measured by Kaplan-Meier method 3 years after study entry
Secondary Outcome Measures
NameTimeMethod
Overall survival as measured by Kaplan-Meier method 3 years after study entry
Progression-free survival as measured by Kaplan-Meier method during events
Complete response rate (orbit, group III only) at completion of study treatment
Rate of toxicity as measured by NCI-CTC v 2.0 3 years after study entry

Trial Locations

Locations (51)

Ibaraki Children's Hospital

🇯🇵

Mito-shi, Ibaraki, Japan

Shiga University of Medical Science

🇯🇵

Otsu-shi, Shiga, Japan

Seirei Hamamatsu General Hospital

🇯🇵

Hamamatsu, Shizuoka, Japan

Kagoshima University

🇯🇵

Kagoshima, Japan

Keio University School of Medicine

🇯🇵

Tokyo, Japan

Aichi Medical University

🇯🇵

Nagakuti, Aichi, Japan

Anjo Kosei Hosptial

🇯🇵

Anjo, Aichi, Japan

Kurume University School of Medicine

🇯🇵

Kurume City, Fukuoka, Japan

Kobe City General Hospital

🇯🇵

Kobe, Hyogo, Japan

Kanazawa Medical University

🇯🇵

Kanazawa, Ishikawa, Japan

National Center for Child Health and Development

🇯🇵

Tokyo, Kanagawa, Japan

Nagano Children's Hospital

🇯🇵

Toyoshina-machi, Nagano, Japan

Showa University Fujigaoka Hospital

🇯🇵

Yokohama-shi, Kanagawa, Japan

Yokohama City University

🇯🇵

Yokohama, Kanagawa, Japan

Miyazaki Medical College University of Miyazaki

🇯🇵

Miyazaki-gun, Miyazaki, Japan

Osaka Medical College

🇯🇵

Takatsuki City, Osaka, Japan

Dokkyo University School of Medicine

🇯🇵

Koshigaya, Saitama, Japan

Shimane Prefectural Central Hospital

🇯🇵

Izumo, Shimane, Japan

Shimane University Hospital

🇯🇵

Izumo, Shimane, Japan

Kyoto Prefectural University of Medicine

🇯🇵

Kyoto, Japan

Gifu University Graduate School of Medicine

🇯🇵

Gifu, Japan

Osaka General Medical Center

🇯🇵

Osaka, Japan

Saitama Children's Medical Center

🇯🇵

Saitama, Japan

St. Luke's International Hospital

🇯🇵

Tokyo, Japan

National Cancer Center Hospital

🇯🇵

Tokyo, Japan

Hokkaido Medical Center for Child Health and Rehabilitation

🇯🇵

Sapporo, Japan

Toho University School of Medicine

🇯🇵

Tokyo, Japan

Toyama University Hospital

🇯🇵

Toyama, Japan

National Kyushu Cancer Center

🇯🇵

Fukuoka-shi, Fukuoka, Japan

Sapporo Medical University

🇯🇵

Sapporo, Hokkaido, Japan

University of Tsukuba

🇯🇵

Tsukuba-city, Ibaraki, Japan

Osaka University Graduate School of Medicine

🇯🇵

Suita-shi, Osaka, Japan

National Hospital Orgnization Nagoya Medical Center

🇯🇵

Nagoya, Aichi, Japan

Ehime Prefectural Central Hospital

🇯🇵

Matsuyama-shi, Ehime, Japan

Gunma Children's Medical Center

🇯🇵

Seta-gun, Gunma, Japan

Gifu Municipal Hospital

🇯🇵

Gifu-shi, Gifu, Japan

National Defense Medical College

🇯🇵

Tokorozawa, Saitama, Japan

Ishikawa Prefectural Central Hospital

🇯🇵

Kanazawa-shi, Ishikawa, Japan

National Hospital Organization - Medical Center of Kure

🇯🇵

Kure, Hiroshima, Japan

Hokkaido University Graduate School of Medicine

🇯🇵

Sapporo, Hokkaido, Japan

Kagoshima City Hospital

🇯🇵

Kagoshima City, Kagoshima, Japan

Osaka City General Hospital

🇯🇵

Suita-shi, Osaka, Japan

Tokyo Metropolitan Kiyose Children's Hospital

🇯🇵

Kiyosei, Tokyo, Japan

Fukushima Medical University Hospital

🇯🇵

Fukushima, Japan

Kyoto University Hospital

🇯🇵

Kyoto, Japan

Osaka Medical Center and Research Institute for Maternal and Child Health

🇯🇵

Izumi, Osaka, Japan

Osaka City University

🇯🇵

Osaka, Japan

Yamagata University Hospital

🇯🇵

Yamagata, Japan

Hiroshima University Hospital

🇯🇵

Hiroshima, Japan

Tokyo Medical and Dental University

🇯🇵

Tokyo, Japan

Nihon University Itabashi Hospital

🇯🇵

Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath